These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 4302508)

  • 1. [Biological and pharmacological studies on Tuberactin, a new antibiotic].
    Nagata A; Hayano K; Hoshino Y
    Kekkaku; 1968 Jul; 43(7):249-53. PubMed ID: 4302508
    [No Abstract]   [Full Text] [Related]  

  • 2. [The experimental studies on antituberculous activity of lividomycin].
    Yamamoto K; Sakurai H; Inoue I; Yamagami K
    Kekkaku; 1972 May; 47(5):135-8. PubMed ID: 4339540
    [No Abstract]   [Full Text] [Related]  

  • 3. The fundamental studies on antituberculous activities of lividomycin.
    Gomi J; Aoyagi T; Torikai K; Yamada Y; Fujino T
    Kekkaku; 1971 Jul; 46(7):265-9. PubMed ID: 4329783
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study on the antituberculous activity of Tuberactin, a new antibiotic].
    Toyohara M
    Kekkaku; 1968 Jul; 43(7):245-8. PubMed ID: 5727835
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of streptomycin-resistance of Mycobacterium tuberculosis on induction rate of resistance to kanamycin, viomycin and capreomycin and on cross-resistance among these drugs].
    Nagata A; Mase M; Yamamoto M; Nakamura H
    Kekkaku; 1969 Jun; 44(6):173-9. PubMed ID: 4308767
    [No Abstract]   [Full Text] [Related]  

  • 6. [Chemical and microbiological detection of liberation of antitubercular agents from emulsions and suspension systems. 2. Capreomycin sulfate, viomycin sulfate and kanamycin sulfate].
    Voigt R; Maa Bared AG
    Pharmazie; 1970; 25(5):342-4. PubMed ID: 4318402
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical study on tuberactinomycin, a new antibiotic].
    Osato T; Toyoara M
    Kekkaku; 1971 May; 46(3):59-63. PubMed ID: 4324041
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dehydroabietylguanidine (DAG), a semisynthetic broad spectrum antibiotic with a special effect on mycobacteria].
    Muftie M
    Z Tuberk Erkr Thoraxorg; 1968 Dec; 129(5):305-10. PubMed ID: 4977376
    [No Abstract]   [Full Text] [Related]  

  • 9. Studies on tuberactinomycin. II. Isolation and properties of tuberactinomycin-N, a new tuberactinomycin group antibiotic.
    Ando T; Matsuura K; Izumi R; Noda T; Take T
    J Antibiot (Tokyo); 1971 Oct; 24(10):680-6. PubMed ID: 5158584
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antituberculous activity of capreomycin and cross resistance to kanamycin, capreomycin and viomycin. 1. In vitro effects of capreomycin on Mycobacterium and the survival of tuberculous mice treated with capreomycin].
    Tanaka K; Saiga S
    Bull Chest Dis Res Inst Kyoto Univ; 1969 Sep; 3(1):36-43. PubMed ID: 5401218
    [No Abstract]   [Full Text] [Related]  

  • 11. [Antituberculous action of a new antibiotic, Lividomycin. Effect on experimental tuberculosis of mice and cross resistance with other antituberculous agents].
    Tsukamura M; Mizuno S; Yamamoto M
    Kekkaku; 1970 Aug; 45(8):263-72. PubMed ID: 4989999
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antituberculous activity of capreomycin and cross resistance to kanamycin, capreomycin, and viomycin. 2. In vitro study of cross resistance to capreomycin, kanamycin and viomycin].
    Tanaka K; Saiga S
    Bull Chest Dis Res Inst Kyoto Univ; 1969 Sep; 3(1):44-51. PubMed ID: 5401219
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies on tuberactinomycin. 3. Isolation and characterization of two minor components, tuberactinomycin B and tuberactinomycin O.
    Izumi R; Noda T; Ando T; Take T; Nagata A
    J Antibiot (Tokyo); 1972 Apr; 25(4):201-7. PubMed ID: 4340567
    [No Abstract]   [Full Text] [Related]  

  • 14. [Resistance pattern of Mycobacterium tuberculosis (H 37 Rv) to a new antibiotic, lividomycin].
    Tsukamura M; Mizuno S
    Kekkaku; 1972 Apr; 47(4):63-7. PubMed ID: 4627477
    [No Abstract]   [Full Text] [Related]  

  • 15. [Preclinical study of therapeutic agents used against Mycobacterium avium complex infections--with special reference to new macrolides and new quinolones].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1996 Sep; 71(9):531-5. PubMed ID: 8999135
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibiotic 6640. 3. Biological studies with antibiotic 6640, a new broad-spectrum aminoglycoside antibiotic.
    Waitz JA; Moss EL; Oden EM; Weinstein MJ
    J Antibiot (Tokyo); 1970 Nov; 23(11):559-65. PubMed ID: 4992170
    [No Abstract]   [Full Text] [Related]  

  • 17. [Interactions of antitubercular drugs. II. Combined effects of rifampin, ethambutol, capreomycin, viomycin, ethionamide and cycloserine on mycobacterial growth in vitro].
    Janowiec M; Zwolska-Kwiek Z
    Pneumonol Pol; 1983 Dec; 51(12):607-12. PubMed ID: 6199778
    [No Abstract]   [Full Text] [Related]  

  • 18. [Chemo-antibiotic-resistance in vitro of "atypical" mycobacteria and Mycobacterium tuberculosis].
    Caroli G; Spaziante G; Mazzarone R
    Riv Ital Ig; 1966; 26(5):535-46. PubMed ID: 4967922
    [No Abstract]   [Full Text] [Related]  

  • 19. Virulence attenuation and other biological modifications in multiple drug resistant tubercle mycobacteria.
    Daddi G; Lucchesi M; Mancini P; Matzeu M; Rossi P; Serafini NA; Termine A; Zubiani M
    Boll Ist Sieroter Milan; 1971; 50(4):353-61. PubMed ID: 5005885
    [No Abstract]   [Full Text] [Related]  

  • 20. [Observations on the chemo-antibiotic-resistance in vitro of more than 400 strains of Mycobacterium tuberculosis recently isolated].
    Spaziante G; Caroli G; Mazzarone R
    Riv Ital Ig; 1966; 26(5):512-34. PubMed ID: 4967921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.